glp-1 drugs what are they New Guidelines for Type 2 Diabetes in 2025 GLP-1 nausea: How to handle

Ma CX, Ma XN, Guan CH, Li YD, Mauricio D, Fu SB

doi: 10.1016/j.pharmthera.2022.108277 103 LinZSurSLiuPLiYJiangDHouXet al

This is not a stimulant or a metabolism booster

Statistical analysis Baseline characteristics of participants were summarized as mean standard deviation (SD) for continuous variables and percentages for categorical variables

How much weight can they expect to lose

Renal and urothelial cancer risks with SGLT2 inhibitors vs GLP-1 receptor agonists in type 2 diabetes: a target trial emulation doi.org/10.1093/ndt/gf Renal and urothelial cancer risks with SGLT2 inhibitors vs GLP-1 receptor agonists in type 2 diabetes: a target trial emulation doi.org/10.1093/ndt/gf